Percentage of women 1) who received or had documented use of most or moderately effective contraception during the postpartum period (primary measure) and 2) received a long-acting reversible contraceptive method during the postpartum period (sub-measure). To focus the measure on the population of women interested in contraceptive services, the denominator excludes those individuals who did not receive or have documented use of a method if they indicated they did not want these services.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Primary measure: All eligible patients who received a most or moderately effective method in the postpartum period
Sub-measure: Of eligible patients, those who received a long-acting reversible contraceptive method (intrauterine device or implant) during the postpartum period.
DenominatorAll women between ages 15-44 with a prenatal care visit between 1/1/XX-1 and 12/31/XX with a live birth date, if documented, or a documented EDD between 10/1/XX-1 and 9/30/XX
Exclusions- Those who indicated they did not want contraceptive services and did not receive or were documented to be using a most or moderately effective method in the postpartum period
- Those who experienced a non-live birth between 10/1/XX-1 and 9/30/XX (e.g. still birth, miscarriage, ectopic pregnancy, or induced abortion)
Testing Data Sources
- Measure StructureClinical Condition Topic AreaNon Condition SpecificTarget Population
- Risk Adjustment
- Current or planned use(s)Current Use(s)
- Most Recent Endorsement ActivityEndorsed Perinatal and Women's Health Spring 2022Initial EndorsementNext Planned Maintenance ReviewPerinatal and Women's Health Spring 2026Endorsement StatusLast Updated
- Steward Organization EmailSteward Organization Copyright
N/A